Caracterización fenotípica de animales modificados genéticamente
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoPublikationen in Zusammenarbeit mit Forschern von AstraZeneca (United Kingdom) (1)
2022
-
Consequences of telomere dysfunction in fibroblasts, club and basal cells for lung fibrosis development
Nature Communications, Vol. 13, Núm. 1